Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tarsus Pharmaceuticals, Inc.

TARS Clue Score56
United States Fiscal year ends December CIK 0001819790 Results filed 3 Nov 2026

What the insiders did Net selling

Bought (120 mo)
$16.53M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$66.87M
$18.07M on a plan · $1.15M straight out of an exercise
Sold at will
$47.66M
191 of 260 sales
Net
−$50.35M
−$31.13M against sales at will